RNS Number : 9555I

Calnex Solutions PLC

21 April 2022

21 April 2022

Calnex Solutions plc

("Calnex", the "Company" or the "Group)

PDMR Dealing

Calnex Solutions plc (AIM: CLX), an established provided of test and measurement solutions for the global telecommunications sector, was informed on 20 April 2022 of the following transactions in the Company's ordinary shares by a PDMR.

The information in the below notification is disclosed in accordance with Article 19 of the EU Market Abuse Regulation.

1          

Details of PDMR/person closely associated with them ("PCA")

1.1      

Name

Jeffrey Wright

1.2      

Position/Status

PDMR - VP Engineering

1.3      

Initial notification / amendment

Initial

2          

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

2.1      

Description of the financial instrument

Ordinary Shares of 0.125 pence each

2.2      

Nature of the transaction

Sale of Ordinary shares

2.3      

Price(s) and volume(s)

Price(s)	Volume(s)
£1.64	20,000

2.4      

Aggregated information

·              Aggregated volume

·              Price

·              Total

20,000

£1.64

£32,800.00

2.5      

Date of the transaction

20/Apr/2022

2.6      

Place of the transaction

London Stock Exchange

For more information, please contact:

Calnex Solutions plc	Via Alma PR
Tommy Cook, Chief Executive Officer Ashleigh Greenan, Chief Financial Officer
Cenkos Securities plc - Nomad	+44 (0)131 220 6939
Derrick Lee / Peter Lynch
Alma PR	+ 44(0) 20 3405 0213
Caroline Forde, Harriet Jackson, Joe Pederzolli

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBKDBNQBKDAQB